Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability-High Metastatic Colorectal Cancer

被引：12

作者：

Hulo, Pauline ^{[1
,4
]}

Touchefeu, Yann ^{[1
,2
]}

Cauchin, Estelle ^{[1
,2
]}

Archambeaud, Isabelle ^{[1
,2
]}

Chapelle, Nicolas ^{[1
,2
]}

Bossard, Celine ^{[3
,4
]}

Bennouna, Jaafar ^{[1
,4
]}

机构：

[1] Ctr Hosp Univ Hotel Dieu, Inst Malad Appareil Digestif, Oncol Digest, F-44000 Nantes, France

[2] Ctr Hosp Univ Hotel Dieu, Serv Hepatogastroenterol, Nantes, France

[3] Ctr Hosp Univ Hotel Dieu, Serv Anat & Cytol Pathol, Nantes, France

[4] Univ Nantes, Univ Angers, INSERM, Ctr Rech Cancerol & Immunol Nantes Angers CRCINA, Nantes, France

来源：

CLINICAL COLORECTAL CANCER | 2020年 / 19卷 / 04期

关键词：

CMV reactivation; Colorectal cancer; Gastritis; Immunotherapy; Toxicity; IPILIMUMAB; NIVOLUMAB;

D O I：

10.1016/j.clcc.2020.04.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E183 / E188

页数：6

共 10 条

[1] Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination [J].

Boutros, Celine ;

Tarhini, Ahmad ;

Routier, Emilie ;

Lambotte, Olivier ;

Ladurie, Francois Leroy ;

Carbonnel, Franck ;

Izzeddine, Hassane ;

Marabelle, Aurelien ;

Champiat, Stephane ;

Berdelou, Armandine ;

Lanoy, Emilie ;

Texier, Matthieu ;

Libenciuc, Cristina ;

Eggermont, Alexander M. M. ;

Soria, Jean-Charles ;

Mateus, Christine ;

Robert, Caroline .

NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (08) :473-486

[2] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline [J].

Brahmer, Julie R. ;

Lacchetti, Christina ;

Schneider, Bryan J. ;

Atkins, Michael B. ;

Brassil, Kelly J. ;

Caterino, Jeffrey M. ;

Chau, Ian ;

Ernstoff, Marc S. ;

Gardner, Jennifer M. ;

Ginex, Pamela ;

Hallmeyer, Sigrun ;

Chakrabarty, Jennifer Holter ;

Leighl, Natasha B. ;

Mammen, Jennifer S. ;

McDermott, David F. ;

Naing, Aung ;

Nastoupil, Loretta J. ;

Phillips, Tanyanika ;

Porter, Laura D. ;

Puzanov, Igor ;

Reichner, Cristina A. ;

Santomasso, Bianca D. ;

Seigel, Carole ;

Spira, Alexander ;

Suarez-Almazor, Maria E. ;

Wang, Yinghong ;

Weber, Jeffrey S. ;

Wolchok, Jedd D. ;

Thompson, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1714-+

[3] Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis [J].

Franklin, Cindy ;

Rooms, Isabelle ;

Fiedler, Melanie ;

Reis, Henning ;

Milsch, Laura ;

Herz, Saskia ;

Livingstone, Elisabeth ;

Zimmer, Lisa ;

Schmid, Kurt Werner ;

Dittmer, Ulf ;

Schadendorf, Dirk ;

Schilling, Bastian .

EUROPEAN JOURNAL OF CANCER, 2017, 86 :248-256

[4] Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study [J].

Hammers, Hans J. ;

Plimack, Elizabeth R. ;

Infante, Jeffrey R. ;

Rini, Brian I. ;

McDermott, David F. ;

Lewis, Lionel D. ;

Voss, Martin H. ;

Sharma, Padmanee ;

Pal, Sumanta K. ;

Razak, Albiruni R. Abdul ;

Kollmannsberger, Christian ;

Heng, Daniel Y. C. ;

Spratlin, Jennifer ;

McHenry, M. Brent ;

Amin, Asim .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) :3851-+

[5] Gastrointestinal complications in patients treated with ipilimumab and nivolumab combination therapy or monotherapy [J].

Irwin, Debra E. ;

Davis, Brian ;

Bell, Jill A. ;

Galaznik, Aaron ;

Garcia-Ribas, Ignacio .

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (02) :81-90

[6] Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis [J].

Lankes, Katharina ;

Hundorfean, Gheorghe ;

Harrer, Thomas ;

Pommer, Ansgar J. ;

Agaimy, Abbas ;

Angelovska, Irena ;

Tajmir-Riahi, Azadeh ;

Goehl, Jonas ;

Schuler, Gerold ;

Neurath, Markus F. ;

Hohenberger, Werner ;

Heinzerling, Lucie .

ONCOIMMUNOLOGY, 2016, 5 (06)

[7]

Larkin J, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]

[8] Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer [J].

Overman, Michael J. ;

Lonardi, Sara ;

Wong, Ka Yeung Mark ;

Lenz, Heinz-Josef ;

Gelsomino, Fabio ;

Aglietta, Massimo ;

Morse, Michael A. ;

Van Cutsem, Eric ;

McDermott, Ray ;

Hill, Andrew ;

Sawyer, Michael B. ;

Hendlisz, Alain ;

Neyns, Bart ;

Svrcek, Magali ;

Moss, Rebecca A. ;

Ledeine, Jean-Marie ;

Cao, Z. Alexander ;

Kamble, Shital ;

Kopetz, Scott ;

Andre, Thierry .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) :773-+

[9] Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data [J].

Soldatos, Theodoros G. ;

Dimitrakopoulou-Strauss, Antonia ;

Larribere, Lionel ;

Hassel, Jessica C. ;

Sachpekidis, Christos .

DIAGNOSTICS, 2018, 8 (04)

[10] Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab [J].

Uslu, Ugur ;

Agaimy, Abbas ;

Hundorfean, Gheorghe ;

Harrer, Thomas ;

Schuler, Gerold ;

Heinzerling, Lucie .

JOURNAL OF IMMUNOTHERAPY, 2015, 38 (05) :212-215

← 1 →